Business Context and Reporting Period
This Form 8-K filing by KALA BIO, Inc. (KALA) reports a significant change in executive leadership effective February 2, 2026. The company is incorporated in Delaware and trades on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Departure: David Lazar resigned as Chief Executive Officer (CEO) and Chief Financial Officer (CFO) effective February 2, 2026. He remains a member of the Board of Directors.
- Appointment: Avi Minkowitz, a current director, was appointed as the new CEO and CFO effective February 2, 2026.
Management Commentary and Background
The Board appointed Mr. Minkowitz to fill the executive vacancy. His background includes:
- Recent Experience: Management Consultant (since 2023) advising on growth, restructuring, and financing; Analyst at Leonite Capital (2021–2024) focusing on financing, M&A, and business development.
- Prior Roles: Vice President at Parkit Enterprise Inc. (2018–2020) sourcing and underwriting real estate acquisitions.
- Entrepreneurship: Founder of Mattress Boyz Inc. and Smart Parking Solutions Canada Inc., both successfully exited.
- Board Service: Currently serves on the boards of NuRAN Wireless Inc. (since November 2025) and International Star Inc. (since October 2022).
Mr. Minkowitz holds a bachelor's degree in psychology and a master's degree in disaster and emergency management from York University. No family relationships or reportable transactions involving Mr. Minkowitz were disclosed.
Investor Verification Checklist
- Verify the effective date of the leadership transition (February 2, 2026).
- Confirm David Lazar's continued status as a Board Director.
- Review Mr. Minkowitz's prior board service and entrepreneurial exits for potential conflicts of interest or strategic alignment.
- Check subsequent filings for any transition agreements or compensation details not included in this 8-K.